Glenmark launches Adapalene Gel USP,0.1% in new pump packs

Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark's Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin?2 Gel, 0.1%.

According to Nielsen? syndicated data for the latest 52-week period ending 05 September2026, the Differin? Gel, 0.1% (OTC) market achieved annual sales of approximately $45.8 million.